ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2,1,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
3,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
3,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
4,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
4,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
4,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
5,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
5,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
5,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
7,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
8,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
9,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
9,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
10,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,Y
11,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
11,2,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
11,3,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
11,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
11,5,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
11,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
12,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
12,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
12,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
13,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
13,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
13,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
13,5,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
14,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
14,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
14,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
14,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
14,5,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
15,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
15,2,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
15,3,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
16,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
16,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
17,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
18,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
19,2,Headache,Headaches NEC,Headaches,Nerv,N
19,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
20,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
20,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
20,3,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
20,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
21,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
22,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
23,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
23,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
24,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
24,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
24,3,Dysdiadochokinesis,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
24,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
24,5,Past-pointing,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
24,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
25,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
25,2,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
25,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
25,4,N-terminal prohormone brain natriuretic peptide increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
25,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
26,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
26,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
26,3,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
26,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
26,5,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
26,6,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
26,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
27,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
27,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
28,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
29,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
30,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
31,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
32,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
32,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,4,Biopsy liver,Hepatobiliary histopathology procedures,Hepatobiliary investigations,Inv,N
32,5,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
32,6,Congestive hepatopathy,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
32,7,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
32,8,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
32,9,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
32,10,Non-alcoholic steatohepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
32,11,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
32,12,Waist circumference increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
33,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
33,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
34,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
35,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
35,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
35,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
36,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
36,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
36,3,Headache,Headaches NEC,Headaches,Nerv,N
37,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
38,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
38,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
39,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,1,Headache,Headaches NEC,Headaches,Nerv,N
40,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
41,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
42,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
42,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
42,3,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
42,4,Pharyngeal erythema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
42,5,Tongue blistering,Tongue signs and symptoms,Tongue conditions,Gastr,N
43,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
43,2,Life support,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
43,3,Lung transplant,Bronchial and pulmonary therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
44,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
44,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
45,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
45,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
45,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
46,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
47,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
47,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
47,3,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
48,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
49,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
50,1,Liver transplant,Hepatic therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
50,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
50,3,Product packaging difficult to open,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
50,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
51,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
51,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
51,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
51,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
51,5,Nasal dryness,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
52,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
52,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
52,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
52,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
52,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
53,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
54,1,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,2,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
55,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
56,1,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
56,3,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
56,4,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
57,1,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
57,2,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
57,3,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
57,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
58,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
60,1,Blood pH increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
60,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
60,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
60,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
61,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
63,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
63,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
63,3,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
64,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
66,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
67,1,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
68,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
69,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
70,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
71,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
72,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
73,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
74,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
75,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
76,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
77,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
78,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
78,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
78,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
79,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
79,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
79,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
80,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
80,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
80,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
81,1,Headache,Headaches NEC,Headaches,Nerv,N
82,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
83,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
84,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
85,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
86,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
87,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
88,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,1,Lung transplant,Bronchial and pulmonary therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
90,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
91,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
92,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
93,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
94,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
95,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
96,1,Eye symptom,Ocular disorders NEC,Eye disorders NEC,Eye,N
96,2,Headache,Headaches NEC,Headaches,Nerv,N
96,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
97,1,Haemoglobin,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
98,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
99,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
100,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,1,Headache,Headaches NEC,Headaches,Nerv,N
102,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
104,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
105,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
106,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
107,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
108,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
109,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
110,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
111,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
112,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
113,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
114,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
115,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
116,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
117,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
118,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
119,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
120,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
121,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
122,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
123,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
124,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
124,2,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
125,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
126,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
127,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
127,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
127,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
128,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
128,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
128,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
129,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
130,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
131,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
132,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
133,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
134,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
